|
Chantix Faces Further FDA Scrutiny (Join Together Online) |
|
|
|
|
Written by Webmaster
|
|
More info... The Food and Drug Administration (FDA) may issue a revision of its warning on Pfizer's controversial smoking-cessation drug Chantix, the Wall Street Journal reported Oct. 23.
Physicians lack smoking cessation training (EurekAlert!)
( American College of Chest Physicians ) New research presented at CHEST 2008 shows that although physicians and other health-care providers advise their patients to quit smoking, few providers have the adequate training to follow their patients through the cessation process.
Hospitals promote wellness through smoking ban (The Times of Northwest Indiana)
Just 15 when she started smoking, Sue Farrell made up her mind this year to quit.
Share Your Opinion. (0 posts)
|